Imatinib 43598-0345-30
- Manufacturer
- Dr.reddy's Laboratories Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 13, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA206547
Need to source Imatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 400 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Selected Package
43598-0345-30Selected30 TABLET in 1 CONTAINER (43598-345-30)
Other packages for this product(3)
500 TABLET in 1 CONTAINER (43598-345-05)
3 BLISTER PACK in 1 CARTON (43598-345-31) / 10 TABLET in 1 BLISTER PACK
90 TABLET in 1 CONTAINER (43598-345-90)